MCL1 and neoplasm: In line with these results, miR-26a overexpression led to reduced expression of anti-apoptotic protein MCL1 (Figure 6D) and significant induction of tumor cell apoptosis, as evidenced by elevated expression of cleaved PARP-1, which was further enhanced when doxorubicin was treated in combination (Figure 6E).